Evidence map›Paper›PMID 42355721›Full record

ReviewJournal of clinical medicine2026

Sequential Field Therapy in Actinic Keratosis: A Mechanism-Based Rationale for Complementary Treatment Strategies.

Giulio Gualdi, Gabriele Soligon, Patrick Silvetti, Leonardo Balestra, Davide Bertolla, Luca Fania, Francesco Ricci, Mario Puviani, Paolo Sbano, Andrea Paradisi

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Giulio GualdiUniversity Hospital, Ospedale Maggiore di Parma, 43126 Parma, Italy.ORCID 0000-0002-1640-6609
Gabriele SoligonUniversity Hospital, Ospedale Maggiore di Parma, 43126 Parma, Italy.
Patrick SilvettiUniversity Hospital, Ospedale Maggiore di Parma, 43126 Parma, Italy.ORCID 0000-0003-0209-3848
Leonardo BalestraUniversity Hospital, Ospedale Maggiore di Parma, 43126 Parma, Italy.ORCID 0009-0000-4466-443X
Davide BertollaUniversity Hospital, Ospedale Maggiore di Parma, 43126 Parma, Italy.ORCID 0009-0000-9700-5542
Luca FaniaSkin Cancer Center, Istituto Dermopatico dell'Immacolata-IRCCS, 00167 Rome, Italy.
Francesco RicciSkin Cancer Center, Istituto Dermopatico dell'Immacolata-IRCCS, 00167 Rome, Italy.ORCID 0000-0002-8388-9268
Mario PuvianiDermatology Clinic, Sassuolo Hospital, 41049 Sassuolo, Italy.ORCID 0000-0003-1792-2581
Paolo SbanoDermatology Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy.
Andrea ParadisiDermatology Unit, Department of Medical, Surgical, Abdominal and Endocrine-Metabolic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

5-fluorouracilactinic keratosisdiclofenacfield cancerizationimiquimodphotodynamic therapysequential treatmenttirbanibulin

Identifiers

PMID42355721
PMCPMC13302536

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.